Trials / Not Yet Recruiting
Not Yet RecruitingNCT06506175
Investigation of Optimal Dosage Regimen for HRS9531 Tablets in Healthy Subjects
A Phase I Clinical Trial to Evaluate the Effects of Different Dosing Conditions, Timing and Food on the Pharmacokinetics of HRS9531 Tablets in Healthy Subjects
- Status
- Not Yet Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 144 (estimated)
- Sponsor
- Fujian Shengdi Pharmaceutical Co., Ltd. · Industry
- Sex
- Male
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The study is being conducted to evaluate the effects of different dosage regimen on the pharmacokinetics of HRS9531 tablets in healthy subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HRS9531 tablets | HRS9531 tablets |
Timeline
- Start date
- 2024-08-05
- Primary completion
- 2024-11-30
- Completion
- 2024-11-30
- First posted
- 2024-07-17
- Last updated
- 2024-07-17
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06506175. Inclusion in this directory is not an endorsement.